Cargando…
The Role of Adjuvant Chemotherapy in Metaplastic Breast Carcinoma: A Competing Risk Analysis of the SEER Database
Purpose: Chemotherapy is the clinically recommended treatment for patients with operable metaplastic breast carcinoma (MBC); however, its impact remains controversial. This study investigated the possible role of chemotherapy in the treatment of MBC. Methods: The Surveillance, Epidemiology, and End...
Autores principales: | Lan, Tian, Lu, Yunyan, Zheng, Ruzhen, Shao, Xiying, Luo, Hua, He, Junling, Yang, Huifen, Xu, Haibin, Wang, Xiaojia, Hu, Zujian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107469/ https://www.ncbi.nlm.nih.gov/pubmed/33981594 http://dx.doi.org/10.3389/fonc.2021.572230 |
Ejemplares similares
-
Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
por: Guo, Qiusheng, et al.
Publicado: (2023) -
The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database
por: Wang, Jun, et al.
Publicado: (2019) -
Research on the Role of Combined Chemotherapy and Radiotherapy in Patients With N+ Non-Metastatic Metaplastic Breast Carcinoma: A Competing Risk Analysis Model Based on the SEER database, 2000 to 2015
por: Ma, Yifei, et al.
Publicado: (2021) -
The role of chemotherapy in patients with T1bN0M0 triple-negative breast cancer: a real-world competing risk analysis
por: Lan, Tian, et al.
Publicado: (2021) -
A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma
por: Lan, Tian, et al.
Publicado: (2019)